Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of drugs. I: studies by in vivo constant infusion.
about
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) modelsA multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk.Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration.The effect of food or water deprivation on paracetamol pharmacokinetics in calves.Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics. III: mechanisms for sinusoidal efflux of 4-methylumbelliferone sulfate.
P2860
Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of drugs. I: studies by in vivo constant infusion.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Pharmacokinetic analysis of fa ...... by in vivo constant infusion.
@en
Pharmacokinetic analysis of fa ...... by in vivo constant infusion.
@nl
type
label
Pharmacokinetic analysis of fa ...... by in vivo constant infusion.
@en
Pharmacokinetic analysis of fa ...... by in vivo constant infusion.
@nl
prefLabel
Pharmacokinetic analysis of fa ...... by in vivo constant infusion.
@en
Pharmacokinetic analysis of fa ...... by in vivo constant infusion.
@nl
P2093
P1433
P1476
Pharmacokinetic analysis of fa ...... by in vivo constant infusion.
@en
P2093
P2860
P304
P356
10.1080/00498250210123094
P407
P577
2002-05-01T00:00:00Z